https://www.selleckchem.com/products/OSI-906.html
In this review, we describe the TME of common lymphoma subtypes with an emphasis on the role of prominent immune checkpoint molecules PD-1 and LAG3. We will also discuss current clinical evidence for ICB in lymphoma and highlight key areas for further investigation where synergistic dual checkpoint blockade of LAG-3 and PD-1 could be used to overcome ICB resistance.In the last ten years, supported by the advances in technologies for unmanned aerial vehicles (UAVs), UAVs have developed rapidly and are utilized for a wide range of applica
پسند
تبصرہ
بانٹیں
